- Home
- VSCO vs LIVN Comparison
VSCO vs LIVN Comparison
Compare VSCO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VSCO | LIVN |
|---|---|---|
| Founded | 1977 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VSCO | LIVN |
|---|---|---|
| Price | $52.03 | $59.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $58.82 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 1.6M | 622.2K |
| Earning Date | 06-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $6,553,000,000.00 | N/A |
| Revenue This Year | $8.77 | $9.79 |
| Revenue Next Year | $3.68 | $6.63 |
| P/E Ratio | $26.18 | ★ N/A |
| Revenue Growth | ★ 5.18 | N/A |
| 52 Week Low | $17.53 | $35.00 |
| 52 Week High | $66.89 | $71.58 |
Technical Indicators
Market Signals| Indicator | VSCO | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 52.94 | 37.24 |
| Support Level | $43.05 | $58.14 |
| Resistance Level | $53.14 | $65.61 |
| Average True Range (ATR) | 2.45 | 2.05 |
| MACD | 0.06 | -0.62 |
| Stochastic Oscillator | 45.02 | 16.95 |
Price Performance
Historical ComparisonAbout VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels. The Company also includes the merchandise sourcing and production function serving the Company and its international partners.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.